Stephen Hoge

This profile gathers the share dealings of Stephen Hoge in Moderna, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 3 May 2021 to 15 October 2026, the count stands at 129 filings.

Sales make up the whole of the open-market record (18 sales, €49.9M). Outside the open market, there are 8 share grants and 103 option exercises. So far in 2026, the count stands at no purchases and 6 sales.

The newest entry dates from 16 October 2026: an option exercise of €833k, in Moderna, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.